# ICON1: Treatment Decisions and Outcomes in Pediatric Refractory ITP

> **NCT01971684** · — · COMPLETED · sponsor: **Boston Children's Hospital** · enrollment: 120 (actual)

## Conditions studied

- Immune Thrombocytopenia

## Interventions

- **DRUG:** Second Line ITP agents

## Key facts

- **NCT ID:** NCT01971684
- **Lead sponsor:** Boston Children's Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2013-08
- **Primary completion:** 2017-04
- **Final completion:** 2017-04
- **Target enrollment:** 120 (ACTUAL)
- **Last updated:** 2020-05-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01971684

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01971684, "ICON1: Treatment Decisions and Outcomes in Pediatric Refractory ITP". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT01971684. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*